Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Vesterhus

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|May 10, 2018
Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine LearningJohn E Eaton, Mette Vesterhus, Bryan M McCauley, et al.
Gut|February 19, 2016
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controlsMartin Kummen, Kristian Holm, Jarl Andreas Anmarkrud, et al.
Plos One|April 9, 2013
Absence of diabetes and pancreatic exocrine dysfunction in a transgenic model of carboxyl-ester lipase-MODY (maturity-onset diabetes of the young)Helge Ræder, Mette Vesterhus, Abdelfattah El Ouaamari, et al.
BMJ Open|June 26, 2024
Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitisNasir Hussain, Christopher Ma, Gideon Hirschfield, et al.
The Journal of Biological Chemistry|July 26, 2011
Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl ester lipase gene-maturity onset diabetes of the young (CEL-MODY): a protein misfolding diseaseBente B Johansson, Janniche Torsvik, Lise Bjørkhaug, et al.
Diabetes|September 25, 2013
Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluidHelge Ræder, Fiona E McAllister, Erling Tjora, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2016
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitisSerge J Zweers, Alexey Shiryaev, Mina Komuta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2017
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre studyElisabeth M G de Vries, Martti Färkkilä, Piotr Milkiewicz, et al.
Journal of Hepatology|June 16, 2023
Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantationPeder Rustøen Braadland, Annika Bergquist, Martin Kummen, et al.
Journal of Hepatology|April 19, 2026
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitisPeder R Braadland, Ahmad H Ali, Philip Puchas, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|May 10, 2018
Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine LearningJohn E Eaton, Mette Vesterhus, Bryan M McCauley, et al.
Gut|February 19, 2016
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controlsMartin Kummen, Kristian Holm, Jarl Andreas Anmarkrud, et al.
Plos One|April 9, 2013
Absence of diabetes and pancreatic exocrine dysfunction in a transgenic model of carboxyl-ester lipase-MODY (maturity-onset diabetes of the young)Helge Ræder, Mette Vesterhus, Abdelfattah El Ouaamari, et al.
BMJ Open|June 26, 2024
Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitisNasir Hussain, Christopher Ma, Gideon Hirschfield, et al.
The Journal of Biological Chemistry|July 26, 2011
Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl ester lipase gene-maturity onset diabetes of the young (CEL-MODY): a protein misfolding diseaseBente B Johansson, Janniche Torsvik, Lise Bjørkhaug, et al.
Diabetes|September 25, 2013
Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluidHelge Ræder, Fiona E McAllister, Erling Tjora, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2016
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitisSerge J Zweers, Alexey Shiryaev, Mina Komuta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2017
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre studyElisabeth M G de Vries, Martti Färkkilä, Piotr Milkiewicz, et al.
Journal of Hepatology|June 16, 2023
Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantationPeder Rustøen Braadland, Annika Bergquist, Martin Kummen, et al.
Journal of Hepatology|April 19, 2026
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitisPeder R Braadland, Ahmad H Ali, Philip Puchas, et al.
Pageof 6